Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Stopped no value in finding efficacy
Conditions
- Prostate Cancer
- Adenocarcinoma of the Prostate
- Hormone-resistant Prostate Cancer
- Recurrent Prostate Cancer
- Stage IV Prostate Cancer
Interventions
- DRUG: vorinostat
- DRUG: temsirolimus
- OTHER: laboratory biomarker analysis
- PROCEDURE: positron emission tomography/computed tomography
Sponsor
Roswell Park Cancer Institute
Collaborators